...
首页> 外文期刊>Cell death & disease. >LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation
【24h】

LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation

机译:LncRNA MIAT海绵通过CD47上调抑制miR-149-5p抑制晚期动脉粥样硬化的红细胞增多

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Atherosclerotic cardio-cerebrovascular disease and death remain the leading cause of morbidity and mortality worldwide. Defective efferocytosis, the clearance of apoptotic cells by macrophages, is thought to lead to increased inflammation and necrotic core formation in atherosclerotic lesions. However, very little is known about the role of long noncoding RNA (lncRNA) during this process. Here we show that lncRNA myocardial infarction associated transcript (MIAT) was markedly elevated in the serum of patients with symptoms of vulnerable atherosclerotic plaque and the macrophages of necrotic cores in an advanced atherosclerosis mouse model. MIAT knockdown attenuated atherosclerosis progression, reduced necrotic core size, and increased plaque stability in vivo. Furthermore, MIAT knockdown promoted clearance of apoptotic cells by macrophages in vivo and in vitro. Mechanistic studies revealed that MIAT acted as a micro RNA (miRNA) sponge to positively modulate the expression of anti-phagocytic molecule CD47 through sponging miR-149-5p. Together, these findings identified a macrophage MIAT/miR-149-5p /CD47 pathway as a key factor in the development of necrotic atherosclerotic plaques.
机译:动脉粥样硬化性心脑血管疾病和死亡仍然是全世界发病率和死亡率的主要原因。缺陷性红细胞增多症(即巨噬细胞清除凋亡细胞)被认为导致动脉粥样硬化病变中炎症增加和坏死核心形成。但是,关于长非编码RNA(lncRNA)在此过程中的作用了解甚少。在这里,我们显示,在晚期动脉粥样硬化小鼠模型中,患有易感性动脉粥样硬化斑块和坏死核心巨噬细胞症状的患者血清中,lncRNA心肌梗死相关转录本(MIAT)明显升高。 MIAT敲低减弱了动脉粥样硬化的进展,减少了坏死核心的大小,并增加了体内的斑块稳定性。此外,MIAT敲低促进体内和体外巨噬细胞清除凋亡细胞。机理研究表明,MIAT充当微小RNA(miRNA)海绵,通过海绵化miR-149-5p来积极调节抗吞噬分子CD47的表达。总之,这些发现确定了巨噬细胞MIAT / miR-149-5p / CD47途径是坏死性动脉粥样硬化斑块形成的关键因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号